Serological markers as predictors of the severity of gastric mucosal atrophy in autoimmune and <i>Helicobacter рylori</i>-associated gastritis

Aim. To evaluate the possibility of using serum markers of atrophy (pepsinogens – PG I and II) to form high-risk groups for gastric cancer (Operative Link for Gastritis Assessment – OLGA stage III–IV) depending on the etiology of gastritis. Materials and methods. A total of 237 (56 men and 181 wo...

Whakaahuatanga katoa

I tiakina i:

Ngā taipitopito rārangi puna kōrero
Ngā kaituhi matua:	Margarita V. Chebotareva, Karine A. Nikolskaya, Dmitry N. Andreev, Alexey S. Dorofeev, Sergey G. Khomeriki, Larisa A. Tsapkova, Elena V. Parfenchikova, Artur M. Veliev, Alexey Yu. Spasenov, Irina N. Voynovan, Dmitry S. Bordin
Hōputu:	Artigo
Reo:	Russo
I whakaputaina:	"Consilium Medicum" Publishing house 2025-01-01
Rangatū:	Терапевтический архив
Ngā marau:	atrophic gastritis autoimmune gastritis gastric cancer serum pepsinogens helicobacter pylori
Urunga tuihono:	https://ter-arkhiv.ru/0040-3660/article/viewFile/681970/205482
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Serological markers as predictors of the severity of gastric mucosal atrophy in autoimmune and <i>Helicobacter рylori</i>-associated gastritis

Ngā tūemi rite